Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Publishing timestamp: 2024-01-26 17:23:53
Summary
The CEOs of Merck and Johnson & Johnson have agreed to testify at an upcoming Senate hearing on high drug prices in the U.S. The hearing is scheduled for February 8th, and the CEOs will be asked to provide testimony on why their companies charge higher prices for medicine in the U.S. compared to other countries. The push to cut drug prices has bipartisan support, and the hearing aims to find solutions to the challenges facing patients.
Sentiment: NEUTRAL
Tickers: MRK, JNJ, SAN-FR, LLY, MRNA, BMY, NOVO.B-DK,
Keywords: health care industry, business, united states, eli lilly and co, moderna inc, merck & co inc, johnson & johnson, biotech and pharmaceuticals, novo nordisk a/s, sanofi sa, business news, biotechnology, pharmaceuticals, bernie sanders, bristol-myers squibb co,